We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
-7.4%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$5.38B
AUM Growth
-$480M
Cap. Flow
+$130M
Cap. Flow %
2.42%
Top 10 Hldgs %
41.73%
Holding
224
New
23
Increased
133
Reduced
36
Closed
13

Top Buys

Rank Stock Value
1
IONS icon
Ionis Pharmaceuticals
IONS
+$23.8M
2
GKOS icon
Glaukos
GKOS
+$20.8M
3
ARVN icon
Arvinas
ARVN
+$19.8M
4
AGIO icon
Agios Pharmaceuticals
AGIO
+$18.4M
5
PACB icon
Pacific Biosciences
PACB
+$13.3M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$72.6M
2
GILD icon
Gilead Sciences
GILD
+$33.8M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$23.2M
4
TDOC icon
Teladoc Health
TDOC
+$19.5M
5
AVDR
Avedro, Inc Common Stock
AVDR
+$15.8M

Sector Composition

Rank Sector Weight
1 Healthcare 94.28%
2 Industrials 0.53%
3 Technology 0.51%
4 Financials 0.07%
5 Consumer Discretionary 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EL icon
176
Estee Lauder
EL
$30.3B
$447K 0.01%
2,248
– –
GGG icon
177
Graco
GGG
$12.2B
$447K 0.01%
9,700
+2,797
+41% +$132K
PAYX icon
178
Paychex
PAYX
$41B
$447K 0.01%
+5,400
New +$449K
HTHT icon
179
Huazhu Hotels Group
HTHT
$12.8B
$446K 0.01%
13,500
+4,156
+44% +$140K
VNE
180
DELISTED
Veoneer, Inc.
VNE
$445K 0.01%
29,700
+20,042
+208% +$325K
AVNT icon
181
Avient
AVNT
$3.31B
$444K 0.01%
13,600
+4,565
+51% +$145K
POOL icon
182
Pool Corp
POOL
$7.33B
$444K 0.01%
2,200
+279
+15% +$53.8K
ICE icon
183
Intercontinental Exchange
ICE
$80.1B
$443K 0.01%
4,800
+963
+25% +$87.9K
MKC icon
184
McCormick & Company Non-Voting
MKC
$14B
$438K 0.01%
5,600
+818
+17% +$65.7K
MKTX icon
185
MarketAxess Holdings
MKTX
$4.08B
$433K 0.01%
1,322
– –
AUTL
186
Autolus Therapeutics
AUTL
$373M
$430K 0.01%
34,600
+600
+2% +$7.93K
AXP icon
187
American Express
AXP
$240B
$426K 0.01%
3,600
+600
+20% +$73.6K
CLX icon
188
Clorox
CLX
$11.6B
$425K 0.01%
+2,800
New +$443K
BR icon
189
Broadridge
BR
$17.4B
$423K 0.01%
3,400
+538
+19% +$69.3K
CERN
190
DELISTED
Cerner Corp
CERN
$423K 0.01%
6,200
+902
+17% +$63.9K
SPGI icon
191
S&P Global
SPGI
$133B
$416K 0.01%
1,700
+156
+10% +$39K
JD icon
192
JD.com
JD
$41.3B
$415K 0.01%
14,700
+2,437
+20% +$73.6K
ADBE icon
193
Adobe
ADBE
$93.3B
$414K 0.01%
1,500
+307
+26% +$89.6K
LYV icon
194
Live Nation Entertainment
LYV
$42.1B
$411K 0.01%
6,200
+1,200
+24% +$83.9K
MCO icon
195
Moody's
MCO
$88.3B
$410K 0.01%
2,000
+142
+8% +$29.8K
XLNX
196
DELISTED
Xilinx Inc
XLNX
$403K 0.01%
+4,200
New +$460K
TYL icon
197
Tyler Technologies
TYL
$13.1B
$400K 0.01%
1,525
– –
ANSS
198
DELISTED
Ansys
ANSS
$399K 0.01%
1,802
– –
VRSN icon
199
VeriSign
VRSN
$25.3B
$396K 0.01%
2,100
+356
+20% +$73.2K
VRSK icon
200
Verisk Analytics
VRSK
$26.4B
$394K 0.01%
2,489
– –
5 6 7
8
9

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Bellevue Group's Q3 2019 Portfolio in Review

As of Q3 2019, Bellevue Group held 224 positions worth $5.38B, down 8.2% from $5.86B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Bellevue Group's Q3 2019 filing shows 23 new, 133 increased, 36 reduced and 13 closed positions. Its largest new stake was Arvinas: 806,403 shares worth $17.4M. The largest sale was Celgene Corp, an estimated $72.6M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 95% a quarter earlier, followed by Industrials and Technology.

  • Bellevue Group's largest Q3 2019 buy was Arvinas: 806,403 shares worth $17.4M.
  • Bellevue Group added most to Ionis Pharmaceuticals in Q3 2019, an estimated $23.8M increase.
  • Bellevue Group's biggest Q3 2019 reduction was Celgene Corp, cutting an estimated $72.6M.
  • Bellevue Group fully exited Avedro, Inc Common Stock in Q3 2019, selling an estimated $15.8M.
  • Bellevue Group's ten largest holdings make up 42% of its $5.38B portfolio in Q3 2019.
  • Bellevue Group opened 23 new positions and closed 13 in Q3 2019.
  • Bellevue Group's portfolio value fell 8.2% quarter-over-quarter to $5.38B.

Based on Bellevue Group's 13F filing for Q3 2019, filed 14 Nov 2019.